FDA Drug Recalls

Recalls / Active ingredient / Lovastatin

Lovastatin

2 FDA drug recalls involving the active ingredient “Lovastatin.

DateClassProductFirm
2019-02-19Class IIILovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NAmerican Health Packaging
2019-02-13Class IIILovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and b) 100-count (NDC 68180-469-01) bLupin Pharmaceuticals Inc.